头颈癌中SDF-1/CXCR4表达与术后放化疗结局的关系
本研究基于德国癌症联盟放疗组多中心生物标志物研究的221例III-IVA期口腔、口咽、下咽鳞癌患者,术后接受≥60Gy放疗联合顺铂化疗,对201例手术标本进行免疫荧光检测SDF-1和CXCR4表达。结果显示细胞内SDF-1高表达与全组及HPV16 DNA阴性亚组较差的局部区域控制独立相关,CXCR4仅单因素分析显示边缘性关联,两者与远处转移-free生存和总生存均无关联。
要点
- 细胞内SDF-1高表达是全组及HPV16 DNA阴性亚组局部区域控制的独立负向预后标志物。
- CXCR4表达仅在单因素分析中显示局部区域控制较差趋势,多因素分析未证实。
- SDF-1和CXCR4表达均未发现与远处转移-free生存或总生存存在关联。
核心结论
- 探索性数据支持细胞内SDF-1过表达是高风险头颈鳞癌术后放化疗后局部区域控制的独立负向预后生物标志物。
- SDF-1/CXCR4作为克服治疗抵抗的潜在治疗靶点值得进一步探索,但需前瞻性验证。
研究设计与样本
- 研究为假设生成性回顾性探索,患者来自德国癌症联盟放疗组(DKTK-ROG)多中心生物标志物研究队列。
- 纳入221例III期和IVA期口腔、口咽、下咽头颈鳞癌患者,均接受手术切除及术后放疗≥60Gy联合顺铂为基础的同步化疗。
- 从手术标本制作组织微阵列(TMA),对201例可评估者用免疫荧光检测SDF-1和CXCR4表达,并与临床病理及结局数据关联。
主要发现
- 单因素和多因素分析中,细胞内SDF-1表达与全组患者及HPV16 DNA阴性亚组较低的局部区域控制(LRC)相关。
- CXCR4表达在单因素分析中显示LRC较低的趋势,但多因素分析未证实。
- SDF-1和CXCR4表达均未发现与远处转移-free生存或总生存存在关联。
关键数值与推荐
- 术后放疗剂量≥60Gy,同步顺铂为基础的化疗。
- 免疫荧光法评估TMA中SDF-1和CXCR4表达,可评估样本201例(总221例)。
临床怎么用
- 细胞内SDF-1高表达可提示术后放化疗后局部区域控制较差的高风险亚组,尤其HPV16 DNA阴性患者。
- SDF-1/CXCR4目前尚不能作为常规临床决策标志物,需前瞻性验证。
局限性
- 本研究为回顾性、假设生成性探索研究。
- SDF-1/CXCR4预后价值的数据此前存在矛盾,需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Outcome after postoperative radiochemotherapy (RT-CT) for patients with advanced head and neck squamous cell carcinomas (HNSCC) remains unsatisfactory, especially among those with HPV negative tumours. Therefore, new biomarkers are needed to further define subgroups for individualised therapeutic approaches. Preclinical and first clinical observations showed that the chemokine receptor CXCR4 and its ligand SDF-1 (CXCL12) play an important role in tumour cell proliferation, survival, cancer progression, metastasis and treatment resistance. However, the data on the prognostic value of SDF-1/CXCR4 expression for HNSCC are conflicting. The aim of our hypothesis-generating study was to retrospectively explore the prognostic potential of SDF-1/CXCR4 in a well-defined cohort of HNSCC patients collected within the multicenter biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). MATERIAL AND METHODS: Patients with stage III and IVA HNSCC of the oral cavity, oropharynx and hypopharynx were treated with resection and adjuvant radiotherapy (RT) with ≥60 Gy and concurrent cisplatin-based chemotherapy (CT). Tissue micro-arrays (TMAs) from a total of 221 patients were generated from surgical specimens, 201 evaluated for the SDF-1 and CXCR4 expression by immunofluorescence and correlated with clinico-pathological and outcome data. RESULTS: In univariate and multivariate analyses intracellular SDF-1 expression was associated with lower loco-regional control (LRC) in the entire patient group as well as in the HPV16 DNA negative subgroup. CXCR4 expression showed a trend for lower LRC in the univariate analysis which was not confirmed in the multivariate analysis. Neither for SDF-1 nor CXCR4 expression associations with distant metastasis free or overall survival were found. CONCLUSIONS: Our exploratory data support the hypothesis that overexpression of intracellular SDF-1 is an independent negative prognostic biomarker for LRC after postoperative RT-CT in high-risk HNSCC. Prospective validation is warranted and further exploration of SDF-1/CXCR4 as a potential therapeutic target to overcome treatment resistance in HNSCC appears promising.
引用
- De-Colle C, Mönnich D, Welz S, et al. SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy. Clin Transl Radiat Oncol. 2017. PMID: 29594214. doi:10.1016/j.ctro.2017.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。